Literature DB >> 35357553

[Surgical treatment of pancreatic cancer-What is new?]

Thomas Schmidt1, Orlin Belyaev2, Waldemar Uhl2, Christiane J Bruns3.   

Abstract

The incidence of pancreatic ductal adenocarcinoma is continuously increasing and will become the second leading cause of cancer-related death in Europe and the USA by 2030. With a 5-year overall survival rate of less than 10% the prognosis remains poor. So far surgical tumor resection remains the only curative treatment option, which is now partially supported by multimodal neoadjuvant and adjuvant therapy concepts. Due to the aggressive tumor biology patients with advanced pancreatic cancer in particular can profit from these multimodal therapy concepts. Additionally, in recent years surgical treatment was optimized, the criteria for tumor resectablity were defined and minimally invasive surgery was widely introduced. This review article summarizes the newest developments and the new German S3 guidelines concerning surgery of pancreatic cancer.
© 2022. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature.

Entities:  

Keywords:  Carcinoma, pancreatic, ductal; Guideline; Neoadjuvant therapy; Resectability criteria; Surgery, indications

Mesh：

Year:  2022        PMID： 35357553     DOI： 10.1007/s00104-022-01618-7

Source DB:  PubMed          Journal:  Chirurg        ISSN： 0009-4722            Impact factor:   0.955


  59 in total

1.  Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  M Ducreux; A Sa Cuhna; C Caramella; A Hollebecque; P Burtin; D Goéré; T Seufferlein; K Haustermans; J L Van Laethem; T Conroy; D Arnold
Journal:  Ann Oncol       Date:  2015-09       Impact factor: 32.976

2.  Validation of at least 1 mm as cut-off for resection margins for pancreatic adenocarcinoma of the body and tail.

Authors:  T Hank; U Hinz; I Tarantino; J Kaiser; W Niesen; F Bergmann; T Hackert; M W Büchler; O Strobel
Journal:  Br J Surg       Date:  2018-05-08       Impact factor: 6.939

3.  Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States.

Authors:  Lola Rahib; Benjamin D Smith; Rhonda Aizenberg; Allison B Rosenzweig; Julie M Fleshman; Lynn M Matrisian
Journal:  Cancer Res       Date:  2014-06-01       Impact factor: 12.701

4.  Cancer Statistics, 2021.

Authors:  Rebecca L Siegel; Kimberly D Miller; Hannah E Fuchs; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2021-01-12       Impact factor: 508.702

Review 5.  International Association of Pancreatology (IAP)/European Pancreatic Club (EPC) consensus review of guidelines for the treatment of pancreatic cancer.

Authors:  Kyoichi Takaori; Claudio Bassi; Andrew Biankin; Thomas B Brunner; Ivana Cataldo; Fiona Campbell; David Cunningham; Massimo Falconi; Adam E Frampton; Junji Furuse; Marc Giovannini; Richard Jackson; Akira Nakamura; William Nealon; John P Neoptolemos; Francisco X Real; Aldo Scarpa; Francesco Sclafani; John A Windsor; Koji Yamaguchi; Christopher Wolfgang; Colin D Johnson
Journal:  Pancreatology       Date:  2015-11-12       Impact factor: 3.996

6.  Pancreatic Cancer Surgery: The New R-status Counts.

Authors:  Oliver Strobel; Thomas Hank; Ulf Hinz; Frank Bergmann; Lutz Schneider; Christoph Springfeld; Dirk Jäger; Peter Schirmacher; Thilo Hackert; Markus W Büchler
Journal:  Ann Surg       Date:  2017-03       Impact factor: 12.969

7.  [Indications for the surgical management of pancreatic neoplasms].

Authors:  Maximilian Brunner; Orlin Belyaev; Florian Bösch; Tobias Keck; Helmut Witzigmann; Robert Grützmann; Waldemar Uhl; Jens Werner
Journal:  Z Gastroenterol       Date:  2021-11-24       Impact factor: 1.769

8.  International consensus on definition and criteria of borderline resectable pancreatic ductal adenocarcinoma 2017.

Authors:  Shuji Isaji; Shugo Mizuno; John A Windsor; Claudio Bassi; Carlos Fernández-Del Castillo; Thilo Hackert; Aoi Hayasaki; Matthew H G Katz; Sun-Whe Kim; Masashi Kishiwada; Hirohisa Kitagawa; Christoph W Michalski; Christopher L Wolfgang
Journal:  Pancreatology       Date:  2017-11-22       Impact factor: 3.996

9.  Structured Reporting of Solid and Cystic Pancreatic Lesions in CT and MRI: Consensus-Based Structured Report Templates of the German Society of Radiology (DRG).

Authors:  Thorsten Persigehl; Matthias Baumhauer; Bettina Baeßler; Lukas Philipp Beyer; Marc Bludau; Christiane Bruns; Alexander Christian Bunck; Christoph-Thomas Germer; Lars Grenacher; Thomas Hackländer; Stefan Haneder; Stefan Heinrich; Philipp Heusch; Matthias Hoffmann; Markus S Juchems; Jan Robert Kröger; Elmar Kotter; Günter Layer; David Maintz; Jan Menke; Moritz Palmowski; Dimitrios Pantelis; Daniel Pinto Dos Santos; Felix Christoph Popp; Nico Schäfer; Heinz-Peter Schlemmer; Andreas G Schreyer; Florian Siedek; Dirk Stippel; Martin Völker; Dirk Thomas Waldschmidt; Tim Frederik Weber; Moritz von Winterfeld; Christian Wybranski; Thomas Zander; Johannes Wessling
Journal:  Rofo       Date:  2020-07-02

10.  Consensus in determining the resectability of locally progressed pancreatic ductal adenocarcinoma - results of the Conko-007 multicenter trial.

Authors:  U A Wittel; D Lubgan; M Ghadimi; O Belyaev; W Uhl; W O Bechstein; R Grützmann; W M Hohenberger; A Schmid; L Jacobasch; R S Croner; A Reinacher-Schick; U T Hopt; A Pirkl; H Oettle; R Fietkau; H Golcher
Journal:  BMC Cancer       Date:  2019-10-22       Impact factor: 4.430
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.